Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Effects of Vestibular-Oriented Balance Training Versus Motor Dual Task Training on Balance, Postural Control, and Fall Risk in Chronic Stroke Survivors

5 août 2026 mis à jour par: Hafsah Arshad, Ibadat International University, Islamabad

Effects of Vestibular-Oriented Balance Training Versus Motor Dual Task Training on Balance, Postural Control, and Fall Risk in Chronic Stroke SurvivorsIIUI/RERC

This randomized controlled trial aims to compare the effectiveness of Vestibular-Oriented Balance Training and Motor Dual Task Training on balance, postural control, and fall risk among chronic stroke survivors. Forty-six participants diagnosed with chronic stroke will be randomly allocated into two intervention groups. Both groups will receive conventional physiotherapy along with their assigned intervention for six weeks. Outcome measures will include the Biodex Balance System (Overall Stability Index, Anterior-Posterior Stability Index, Medial-Lateral Stability Index and Fall Risk Index), Modified clinical test of sensory interaction on balance( m-CTISB). The findings will provide evidence regarding the most effective rehabilitation strategy for improving, Overall stability, and functional balance and reducing fall risk in chronic stroke survivors.

Aperçu de l'étude

Statut

Recrutement

Intervention / Traitement

Description détaillée

Stroke is one of the leading causes of long-term disability worldwide and is associated with significant impairments in balance, postural control, mobility, and functional independence. Balance dysfunction remains one of the most challenging complications in chronic stroke survivors despite conventional rehabilitation interventions.

Vestibular-Oriented Balance Training (VOBT) is an evidence-based rehabilitation approach designed to improve balance by stimulating the vestibular system and enhancing sensory integration. This intervention includes exercises involving head movements, gaze stabilization, balance challenges on stable and unstable surfaces, dynamic postural tasks, and coordinated body movements.

Although both Vestibular-Oriented Balance Training and Motor Dual Task Training have demonstrated beneficial effects individually, there is limited high-quality evidence directly comparing their effectiveness in improving balance, postural control, and fall risk among chronic stroke survivors. Identifying the more effective rehabilitation strategy would assist physiotherapists in selecting evidence-based interventions that optimize patient recovery and functional independence.

The present study is designed as a randomized controlled trial to compare the effects of Vestibular-Oriented Balance Training and Motor Dual Task Training on balance, postural control, and fall risk in individuals with chronic stroke. A total of 50 eligible participants diagnosed with chronic stroke will be recruited using predefined inclusion and exclusion criteria. Participants will be randomly allocated into two parallel intervention groups using a computer-generated randomization sequence.

Participants allocated to the experimental group will receive Vestibular-Oriented Balance Training in addition to conventional physiotherapy. The intervention will consist of progressive vestibular exercises including gaze stabilization, head movement exercises, balance training on different support surfaces, weight-shifting activities, dynamic standing balance tasks, reaching activities, stepping exercises, and functional gait activities. The intensity and difficulty of the exercises will be progressively increased according to each participant's performance and tolerance throughout the intervention period.

Participants allocated to the active comparator group will receive Motor Dual Task Training together with the same conventional physiotherapy program. The intervention will include simultaneous performance of balance and mobility tasks combined with functional motor activities such as walking while carrying objects, obstacle negotiation, reaching during standing, stepping while manipulating objects, and other progressively challenging motor dual-task exercises. Exercise progression will be individualized according to participant performance to ensure safety and maximize functional improvement.

Both groups will receive intervention sessions three times per week for five consecutive weeks. Each treatment session will last approximately 45 to 60 minutes. Conventional physiotherapy will be standardized across both groups to ensure that the only difference between groups is the assigned experimental intervention.

Type d'étude

Interventionnel

Inscription (Estimé)

50

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

Sauvegarde des contacts de l'étude

  • Nom: Ijaz Ahmed, MS-NMPT
  • Numéro de téléphone: +923437149637
  • E-mail: ejaza788@gmail.com

Lieux d'étude

      • Rawalpindi, Pakistan, 46000
        • Recrutement
        • Armed Forces Institute of Rehabilitation Medicine Rawalpindi, Pakistan
        • Contact:

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

  • Adulte
  • Adulte plus âgé

Accepte les volontaires sains

Non

La description

Inclusion Criteria:

  • Diagnosis of ischemic stroke.
  • Stroke duration ≥6 months.
  • Rhomberg scale
  • MMSE ≥ 24
  • Able to walk with or without assistive device.
  • Able to understand commands
  • Willing to participate and provide consent aged between 40-70 years.

Exclusion Criteria:

  • Severe visual impairements which effect balance.
  • Participants with acute or sub acute stroke <6 moths.
  • Uncontrolled hypertension
  • Uncontrolled diabetes
  • Other neurological disorders such as Parkinson's disease or multiple sclerosis and Alzheimer's
  • Participation in any other interventional trail.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Traitement
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Seul

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Vestibular-Oriented Balance Training
Participants will receive vestibular-oriented balance exercises together with conventional physiotherapy for five weeks
Participants will receive vestibular-oriented balance exercises together with conventional physiotherapy for five weeks
Comparateur actif: Motor Dual Task Training
Participants will receive motor dual-task balance training together with conventional physiotherapy for five weeks
Participants will receive motor dual-task balance training together with conventional physiotherapy for five weeks.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Biodex Over all stability Index
Délai: assessment at baseline and after 6 weeks
Overall Stability Index (OSI) on the Biodex Balance System is a comprehensive score measuring how well a person controls their balance and keeps a moving platform level. Higher numbers mean more platform tilt and poorer balance control, while lower numbers show better stability and stronger neuromuscular coordination.
assessment at baseline and after 6 weeks
Biodex Fall Risk index
Délai: at baseline and after 6 weeks
It measures a person's stability and risk of falling by tracking how much they sway on a moveable balance platform. Higher scores indicate poor stability and a higher likelihood of falls
at baseline and after 6 weeks
Modified clinical test of sensory interaction on balance
Délai: at baseline and after 6 weeks
a clinical tool used to evaluate static postural control and identify which sensory systems (vision, vestibular, or somatosensory/proprioceptive) a patient relies on or struggles with to maintain balance.
at baseline and after 6 weeks

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Biodex APSI
Délai: at baseline and after 6 weeks
Anterior/Posterior Stability Index (APSI) on the Biodex Balance System measures front-to-back postural sway and balance ability. Higher scores indicate greater platform displacement and poorer stability, while lower scores reflect better front-to-back neuromuscular control and stability.
at baseline and after 6 weeks
Biodex Medial/Lateral Stability Index
Délai: at baseline and after 6 weeks
A lower score indicates better stability, meaning the person stayed closer to the center level. A higher score represents greater side-to-side sway, indicating poor postural performance or a higher risk of falling.
at baseline and after 6 weeks

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Estimé)

10 juillet 2026

Achèvement primaire (Estimé)

15 novembre 2026

Achèvement de l'étude (Estimé)

18 décembre 2026

Dates d'inscription aux études

Première soumission

5 août 2026

Première soumission répondant aux critères de contrôle qualité

5 août 2026

Première publication (Réel)

10 août 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

10 août 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

5 août 2026

Dernière vérification

1 août 2026

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner